SCHEMBL7899013

SCHEMBL7899013

CC(=O)/C=C/c1ccccc1C

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.66
LMNA P02545 3/20 0.66
KDM4E B2RXH2 3/20 0.59
IAPP P10997 1/20 0.56
GLA P06280 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
ALDH1A1 P00352 3/20 0.50
TSHR P16473 2/20 0.50
RAB9A P51151 2/20 0.48
KMT2A Q03164 2/20 0.45
ATM Q13315 1/20 0.45
MEN1 O00255 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
GMNN O75496 1/20 0.44
PMP22 Q01453 1/20 0.44
NFE2L2 Q16236 2/20 0.44
NFKB1 P19838 2/20 0.44
JUN P05412 1/20 0.44
CYP1A2 P05177 2/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14279409 1.00 MAPT (0.66) MAPTLMNAKDM4EIAPPGLA
SCHEMBL2834883 1.00 MAPT (0.66) MAPTLMNAKDM4EIAPPGLA
SCHEMBL31422587 1.00 MAPT (0.66) MAPTLMNAKDM4EIAPPGLA
SCHEMBL14441077 0.87 MAPT (0.76) MAPTLMNAKDM4EIAPPGLA
SCHEMBL15853343 0.86 LMNA (0.50) MAPTLMNAKDM4EIAPPGLA
SCHEMBL5598952 0.85 NFE2L2 (0.61) MAPTLMNAKDM4ETDP1ALDH1A1
SCHEMBL5598954 0.85 NFE2L2 (0.61) MAPTLMNAKDM4ETDP1ALDH1A1
SCHEMBL78556 0.83 CA1 (0.62) MAPTLMNAKDM4EALDH1A1TSHR
SCHEMBL78555 0.83 CA1 (0.62) MAPTLMNAKDM4EALDH1A1TSHR
SCHEMBL2425317 0.83 CA1 (0.62) MAPTLMNAKDM4EALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110713436-B Method for carrying out 1, 4-conjugated reduction by photochemical catalysis of alpha, beta-ketene compound 北京工商大学 2022-06-14 CN claimed
EP-4727923-A1 TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA University of Georgia Research Foundation, Inc. (US) 2026-04-22 EP disclosed
US-20260098012-A1 TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA UNIV GEORGIA (US) 2026-04-09 US disclosed
WO-2024258904-A1 TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2024-12-19 WO disclosed
US-11807619-B2 Para acyl substituted diazacyclohexene derivatives Renovel Innovations, Inc. 2023-11-07 US disclosed
US-11807619-B2 Para acyl substituted diazacyclohexene derivatives Renovel Innovations, Inc. 2023-11-07 US disclosed
CN-110713436-B Method for carrying out 1, 4-conjugated reduction by photochemical catalysis of alpha, beta-ketene compound 北京工商大学 2022-06-14 CN disclosed
CN-112266352-B Piperlongumine derivative and preparation method and application thereof 绍兴文理学院 2022-02-08 CN disclosed
CN-112266352-A Piperlongumine derivative and preparation method and application thereof 绍兴文理学院 2021-01-26 CN disclosed
CN-110713436-A Method for carrying out 1, 4-conjugated reduction by photochemical catalysis of alpha, beta-ketene compound 北京工商大学 2020-01-21 CN disclosed
US-9102665-B2 Cysteinyl leukotriene antagonists SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) 2015-08-11 US disclosed
US-20140155596-A1 CYSTEINYL LEUKOTRIENE ANTAGONISTS SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) 2014-06-05 US disclosed
US-6177462-B1 Unsaturated oxime ethers and their use as fungicides and insecticides ROHM AND HAAS COMPANY 2001-01-23 US disclosed
EP-0936213-A1 Unsaturated oxime ethers and their use as fungicides and insecticides ROHM AND HAAS COMPANY (US) 1999-08-18 EP disclosed
US-5484949-A Method for the synthesis of α β-unsaturated ketones NIPPON SODA CO., LTD. (JP) 1996-01-16 US disclosed
EP-0195053-B1 PROCESS FOR PREPARING 1,3-CYCLOHEXANEDIONE DERIVATIVES AND INTERMEDIATES THEREFOR CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) 1992-02-12 EP disclosed
EP-0454867-A1 A METHOD FOR THE SYNTHESIS OF -g(a), -g(b)-UNSATURATED KETONES. NIPPON SODA CO (JP) 1991-11-06 EP disclosed
WO-1991007370-A1 A METHOD FOR THE SYNTHESIS OF α, β-UNSATURATED KETONES NIPPON SODA CO., LTD. (JP) 1991-05-30 WO disclosed
EP-0195053-A1 PROCESS FOR PREPARING 1,3-CYCLOHEXANEDIONE DERIVATIVES AND INTERMEDIATES THEREFOR. CHEVRON RES & TECH (US) 1986-09-24 EP disclosed
WO-1986002065-A1 PROCESS FOR PREPARING 1,3-CYCLOHEXANEDIONE DERIVATIVES AND INTERMEDIATES THEREFOR CHEVRON RESEARCH COMPANY (US) 1986-04-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11807619-B2 Para acyl substituted diazacyclohexene derivatives AADAC, TBXA2R, DPP8 MAPT 4652/4885LMNA 1601/4885KDM4E 2000/4885
US-20260098012-A1 TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA CD47, SLC11A2, G6PD MAPT 2146/4885LMNA 297/4885KDM4E 1264/4885
US-20140155596-A1 CYSTEINYL LEUKOTRIENE ANTAGONISTS LTC4S, CYSLTR2, CYSLTR1 MAPT 4832/4885LMNA 1681/4885KDM4E 2559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.